Post by DINAMIQS

DINAMIQS today announced that it has received the manufacturing and testing license from Swissmedic for viral vector cGMP production. With this approval, DINAMIQS is now authorized to manufacture and release Advanced Therapeutic Medicinal Products (ATMP) under GMP conditions – marking a key step in supporting customers across the globe on their path to patients. Read the media release: https://lnkd.in/eEWJRfAB